Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-27

Clinical Trial Update: Is Medicinal Cannabis an Effective Treatment for Tourette Syndrome in Adolescents? a Pilot Study [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 pilot study evaluating medicinal cannabis for Tourette syndrome in adolescents.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Medicinal Cannabis (cannabis)

Snippet

Sponsor: Murdoch Childrens Research Institute | Conditions: Tourette Syndrome in Adolescence | Phase 1, Phase 2 | Status: COMPLETED